CDK9/10/GSK3β-IN-1

Modify Date: 2024-01-10 23:51:50

CDK9/10/GSK3β-IN-1 Structure
CDK9/10/GSK3β-IN-1 structure
Common Name CDK9/10/GSK3β-IN-1
CAS Number 2423045-06-9 Molecular Weight 546.04
Density N/A Boiling Point N/A
Molecular Formula C29H24ClN3O4S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of CDK9/10/GSK3β-IN-1


CDK9/10/GSK3β-IN-1 (compound 13c) is a kinase inhibitor (Flavopiridol (HY-10005) analogue) that effectively inhibits HsGSK3β (IC50=59 nM), HsCDK9/CyclinT (IC50=64 nM), HsCDK5/p25 (IC50=1.093 µM) and HsCDK2/CyclinA (IC50=1.725 µM). CDK9/10/GSK3β-IN-1 has anti-cancer cellular activity comparable to or higher than that of Flavopiridol. CDK9/10/GSK3β-IN-1 shows high anti-proliferative activity in vitro against up to seven cancer cell lines[1].

 Names

Name CDK9/10/GSK3β-IN-1

 CDK9/10/GSK3β-IN-1 Biological Activity

Description CDK9/10/GSK3β-IN-1 (compound 13c) is a kinase inhibitor (Flavopiridol (HY-10005) analogue) that effectively inhibits HsGSK3β (IC50=59 nM), HsCDK9/CyclinT (IC50=64 nM), HsCDK5/p25 (IC50=1.093 µM) and HsCDK2/CyclinA (IC50=1.725 µM). CDK9/10/GSK3β-IN-1 has anti-cancer cellular activity comparable to or higher than that of Flavopiridol. CDK9/10/GSK3β-IN-1 shows high anti-proliferative activity in vitro against up to seven cancer cell lines[1].
Related Catalog
Target

IC50: 59 nM (HsGSK3β), 64 nM (HsCDK9/CyclinT), 1.093 µM (HsCDK5/p25), 1.725 µM (HsCDK2/CyclinA)[1].

In Vitro CDK9/10/GSK3β-IN-1 (series concentration,72 h) exhibits high antiproliferative activity to SKOV3, NCIeN87, SKBR3, PC3, MiaPaCa-2, HCT116, K562 cells[1]. Cell Proliferation Assay[1] Cell Line: SKOV3, NCIeN87, SKBR3, PC3, MiaPaCa-2, HCT116, K562 cells Concentration: Series concentration Incubation Time: 72 h Result: Showed high antiproliferative activity, with an IC50 < 100 nM on 6 cancer cell lines, and up to six times more potent on the pancreatic cancer cells (MiaPaCa-2) than the reference compound, flavopiridol.
References

[1]. Ibrahim N, et al. Identification of a new series of flavopiridol-like structures as kinase inhibitors with high cytotoxic potency. Eur J Med Chem. 2020 Aug 1;199:112355.

 Chemical & Physical Properties

Molecular Formula C29H24ClN3O4S
Molecular Weight 546.04
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.